Atiprimod's Effects on Multiple Myeloma Cells
Author Information
Author(s): Amit-Vazina M, Shishodia S, Harris D, Van Q, Wang M, Weber D, Alexanian R, Talpaz M, Aggarwal B B, Estrov Z
Primary Institution: The University of Texas M.D. Anderson Cancer Center
Hypothesis
Atiprimod inhibits multiple myeloma cell proliferation and induces apoptosis by blocking IL-6 signaling.
Conclusion
Atiprimod effectively inhibits the growth of multiple myeloma cells and induces apoptosis through the suppression of STAT3 activation.
Supporting Evidence
- Atiprimod inhibited the proliferation of multiple myeloma cell lines in a dose-dependent manner.
- Atiprimod induced apoptosis in U266-B1 cells through the activation of caspase 3.
- Atiprimod downregulated the levels of antiapoptotic proteins Bcl-2, Bcl-XL, and Mcl-1.
- Atiprimod suppressed IL-6 production in multiple myeloma cells.
Takeaway
Atiprimod is a drug that helps stop cancer cells from growing and can make them die, which is good news for treating multiple myeloma.
Methodology
The study involved treating multiple myeloma cell lines and primary cells from patients with Atiprimod and assessing cell proliferation, apoptosis, and signaling pathways.
Limitations
The study was limited to a small sample size and focused on specific myeloma cell lines.
Participant Demographics
Five patients with newly diagnosed multiple myeloma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website